Literature DB >> 16142238

BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.

Ryan T Phan1, Masumichi Saito, Katia Basso, Huifeng Niu, Riccardo Dalla-Favera.   

Abstract

The BCL6 proto-oncogene encodes a transcriptional repressor that is required for germinal center formation and has been linked to lymphomagenesis. BCL6 functions by directly binding to specific DNA sequences and suppressing the transcription of target genes. Here we report an alternative mechanism by which BCL6 controls the transcription of genes lacking a BCL6 binding site and show that this mechanism was required for the prevention of tumor suppressor p53-independent cell cycle arrest in germinal center B cells. BCL6 interacted with the transcriptional activator Miz-1 and, via Miz-1, bound to the promoter and suppressed transcription of the cell cycle arrest gene CDKN1A. Through this mechanism, BCL6 may facilitate the proliferative expansion of germinal centers during the normal immune response and, when deregulated, the pathological expansion of B cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142238     DOI: 10.1038/ni1245

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  154 in total

1.  A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.

Authors:  Wyndham H Wilson; Sin-Ho Jung; Pierluigi Porcu; David Hurd; Jeffrey Johnson; S Eric Martin; Myron Czuczman; Raymond Lai; Jonathan Said; Amy Chadburn; Dan Jones; Kieron Dunleavy; George Canellos; Andrew D Zelenetz; Bruce D Cheson; Eric D Hsi
Journal:  Haematologica       Date:  2011-12-01       Impact factor: 9.941

Review 2.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

3.  EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis.

Authors:  Irina Velichutina; Rita Shaknovich; Huimin Geng; Nathalie A Johnson; Randy D Gascoyne; Ari M Melnick; Olivier Elemento
Journal:  Blood       Date:  2010-08-24       Impact factor: 22.113

Review 4.  Prognostic markers in diffuse large B-cell lymphoma: Keys to the underlying biology.

Authors:  Jane N Winter
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

5.  Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494.

Authors:  Jane N Winter; Shuli Li; Vikas Aurora; Daina Variakojis; Beverly Nelson; Maryla Krajewska; Lijun Zhang; Thomas M Habermann; Richard I Fisher; William R Macon; Mukesh Chhanabhai; Raymond E Felgar; Eric D Hsi; L Jeffrey Medeiros; James K Weick; Edie A Weller; Ari Melnick; John C Reed; Sandra J Horning; Randy D Gascoyne
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

6.  A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs.

Authors:  Nate P Hoverter; Ju-Hui Ting; Suman Sundaresh; Pierre Baldi; Marian L Waterman
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

7.  Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets.

Authors:  Micah D Gearhart; Connie M Corcoran; Joseph A Wamstad; Vivian J Bardwell
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

8.  Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.

Authors:  Min-Kyeong Kim; Bu-Nam Jeon; Dong-In Koh; Kyung-Sup Kim; So-Yoon Park; Chae-Ok Yun; Man-Wook Hur
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

9.  Checkpoint kinase 2 is required for efficient immunoglobulin diversification.

Authors:  Kathrin Davari; Samantha Frankenberger; Angelika Schmidt; Nils-Sebastian Tomi; Berit Jungnickel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  Molecular pathology of lymphoma.

Authors:  S E Coupland
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.